home All News open_in_new Full Article

NHS becomes first health service in Europe to offer new cancer jab

Nivolumab is a monoclonal antibody that works by binding to a protein called PD-1 on a type of immune cell called T-cell.


today 11 h. ago attach_file Science

attach_file Politics
attach_file Politics
attach_file Science
attach_file Science
attach_file Events
attach_file Science
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Science
attach_file Events
attach_file Politics
attach_file Sport
attach_file Events
attach_file Politics
attach_file Science
attach_file Events


ID: 1584712454
Add Watch Country

arrow_drop_down